WO2005123780A3

Alteration of fcrn binding affinities or serum half-lives of antibodies by mutagenesis

Abstract

The present invention provides for a modified antibody of class IgG, in which at least one amino acid from the heavy chain constant region selected from the group consisting of amino acid residues 250, 314, and 428 is substituted with another amino acid which is different from that present in the unmodified antibody, thereby altering the binding affinity for FcRn and/or the serum half-life in comparison to the unmodified antibody.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

Every citation, both ways

Citations
DocumentRelationOfficeCited during
US2002142000A1CitesUnited States of AmericaInternational search
US6197297B1CitesUnited States of AmericaInternational search
US6388487B1CitesUnited States of AmericaInternational search
US7163681B2CitesUnited States of AmericaInternational search